# India takes legal action against Nestle over baby food claims

> Food regulator files cases over promotional violations and biotin content in infant nutrition products.
- Title: India takes legal action against Nestle over baby food claims
- Summary: Food regulator files cases over promotional violations and biotin content in infant nutrition products. FSSAI filed three cases against Nestle India for…
- Keywords: nestle india, fssai, infant nutrition, nan excella pro, lactogen pro, biotin violation, food safety, india, legal action, infant formula, promotional claims, takes
- Source: The Economic Times — https://economictimes.indiatimes.com/industry/cons-products/food/fssai-initiates-legal-action-against-nestle-india-over-infant-nutrition-claims-and-biotin-violation/articleshow/134342255.cms
- Author: ET Bureau
- Published: 2026-09-18T18:29:00+00:00
- Read time: 1 min
- Topics: nestle india, fssai, infant nutrition, nan excella pro, lactogen pro, biotin violation, food safety, india, legal action, infant formula, promotional claims
## Legal action over baby formula
FSSAI filed three cases against Nestle India over violations involving NAN Excella Pro Stage 1 and Lactogen Pro 1 infant nutrition products.
## Inappropriate promotional claims found
The regulator found claims about "5 HMOs" and easy-to-digest whey protein on ecommerce platforms were not appropriate for infant formula.
## Regulations prohibit promotional material
Both products violated 2020 regulations that restrict promotional claims intended to increase the saleability of infant foods.
## Biotin levels found substandard
A follow-up formula sample failed to meet required biotin content. A referral laboratory confirmed the water-soluble B vitamin deficiency.
## Nestle says products are compliant
The company stated its products and labels were approved by FSSAI's expert committee and claims are supported by scientific literature.

> Our products are fully compliant with all applicable regulations.
## Key takeaway

FSSAI filed three cases against Nestle India for inappropriate promotional claims on infant formula and substandard biotin levels.